Pacific Biosciences of California, Inc.
PACBMedical Devices
$2.61−10.17%As of Oct 30vs prior close
- Market cap
- $809.7M
- P/E (TTM)
- –
- From 52W high
- −10.17%
- EPS (LTM)
- -$0.41
- Revenue (LTM)
- $159.3M
- Net margin
- -82.49%
Nomior Score
27
Steady ProfileSpeculativeBottom 13% of the scored universe
Growth52
Quality32
Value36
Momentum45
Resilience23
Growth
+6.51%revenue a year over 9 fiscal years
YE16 $90.7MLTM $159.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 114% of revenue, wider by 2 pts on a year.
Who owns it
2funds, 1 tracked portfolio